Growth Metrics

Pfizer (PFE) Minority Interest (2016 - 2026)

Pfizer has reported Minority Interest over the past 18 years, most recently at $303.0 million for Q1 2026.

  • Quarterly Minority Interest rose 1.34% to $303.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $303.0 million through Mar 2026, up 1.34% year-over-year, with the annual reading at $299.0 million for FY2025, 1.7% up from the prior year.
  • Minority Interest was $303.0 million for Q1 2026 at Pfizer, up from $299.0 million in the prior quarter.
  • Over five years, Minority Interest peaked at $317.0 million in Q2 2025 and troughed at $227.0 million in Q4 2022.
  • The 5-year median for Minority Interest is $274.0 million (2023), against an average of $277.6 million.
  • Year-over-year, Minority Interest decreased 18.64% in 2022 and then grew 18.94% in 2023.
  • A 5-year view of Minority Interest shows it stood at $256.0 million in 2022, then increased by 7.03% to $274.0 million in 2023, then grew by 7.3% to $294.0 million in 2024, then increased by 1.7% to $299.0 million in 2025, then rose by 1.34% to $303.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Minority Interest are $303.0 million (Q1 2026), $299.0 million (Q4 2025), and $295.0 million (Q3 2025).